NICORETTE description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

NICORETTE

GlaxoSmithKline Consumer Healthcare LP

Drug Facts


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Nicotine polacrilex, 2mg

Nicotine polacrilex, 4mg

Stop smoking aid

  • •reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider.

Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Ask a doctor before use if you have

  • •a sodium-restricted diet
  • •heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
  • •high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
  • •stomach ulcer or diabetes

Ask a doctor or pharmacist before use if you are

  • •using a non-nicotine stop smoking drug
  • •taking prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

Stop use and ask a doctor if

  • •mouth problems occur
  • •persistent indigestion or severe sore throat occurs
  • •irregular heartbeat or palpitations occur
  • •you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat

Keep out of reach of children and pets.

Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.

  • if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
  • •before using this product, read the enclosed User’s Guide for complete directions and other important information
  • •begin using the lozenge on your quit day
  • if you smoke your first cigarette within 30 minutes of waking up, use 4mg nicotine lozenge
  • if you smoke your first cigarette more than 30 minutes after waking up, use 2mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6

Weeks 7 to 9

Weeks 10 to 12

1 lozenge every 1 to 2 hours

1 lozenge every 2 to 4 hours

1 lozenge every 4 to 8 hours

  • nicotine lozenge is a medicine and must be used a certain way to get the best results
  • •place the lozenge in your mouth and allow the lozenge to slowly dissolve (about 20 - 30 minutes). Minimize swallowing. Do not chew or swallow lozenge.
  • •you may feel a warm or tingling sensation
  • •occasionally move the lozenge from one side of your mouth to the other until completely dissolved (about 20 - 30 minutes)
  • •do not eat or drink 15 minutes before using or while the lozenge is in your mouth
  • •to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
  • •do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
  • do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
  • •it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.
  • if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
  • •before using this product, read the enclosed User’s Guide for complete directions and other important information
  • •begin using the lozenge on your quit day
  • if you smoke your first cigarette more than 30 minutes after waking up, use 2mg nicotine lozenge
  • if you smoke your first cigarette within 30 minutes of waking up, use 4mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6

Weeks 7 to 9

Weeks 10 to 12

1 lozenge every 1 to 2 hours

1 lozenge every 2 to 4 hours

1 lozenge every 4 to 8 hours

  • nicotine lozenge is a medicine and must be used a certain way to get the best results
  • •place the lozenge in your mouth and allow the lozenge to slowly dissolve (about 20 - 30 minutes). Minimize swallowing. Do not chew or swallow lozenge.
  • •you may feel a warm or tingling sensation
  • •occasionally move the lozenge from one side of your mouth to the other until completely dissolved (about 20 - 30 minutes)
  • •do not eat or drink 15 minutes before using or while the lozenge is in your mouth
  • •to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
  • •do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
  • do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
  • •it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.
  • each lozenge contains: sodium, 18mg
  • •Phenylketonurics: Contains Phenylalanine 3.4 mg per lozenge
  • •store at 20 - 25°C (68 - 77°F)
  • •protect from light
  •  NICORETTE, and the NICORETTE sunburst design are registered trademarks of the GlaxoSmithKline group of companies.

Distributed By:

GlaxoSmithKline Consumer Healthcare, L.P.

Moon Township, PA 15108

Made in the Switzerland

  • •not for sale to those under 18 years of age
  • •proof of age required
  • •not for sale in vending machines or from any source where proof of age cannot be verified

This product is protected in sealed blisters.

Do not use if individual blisters or printed backings are broken, open, or torn

TO INCREASE YOUR SUCCESS IN QUITTING:

  • 1.You must be motivated to quit.
  • 2. Use Enough - Use at least 9 Nicorette Lozenges per day during the first six weeks.
  • 3. Use Long Enough - Use Nicorette for the full 12 weeks.
  • 4. Use With a Support Program as directed in the enclosed User’s Guide.

To remove the lozenge, tear off single unit.

Peel off backing starting at corner with loose edge.

Push lozenge through foil.

For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.com or see inside for more details

  • each lozenge contains: sodium, 18mg
  • •Phenylketonurics: Contains Phenylalanine 3.4 mg per lozenge
  • •store at 20 - 25°C (68 - 77°F)
  • •keep POPPAC tightly closed and protect from light
  •  NICORETTE, POPPAC and the NICORETTE sunburst design are registered trademarks of the GlaxoSmithKline group of companies.

Distributed By:

GlaxoSmithKline Consumer Healthcare, L.P.

Moon Township, PA 15108

Made in the Switzerland

  • •not for sale to those under 18 years of age
  • •proof of age required
  • •not for sale in vending machines or from any source where proof of age cannot be verified

TAMPER EVIDENT FEATURE: Do not use if clear neckband printed “SEALED FOR SAFETY” is missing or broken.

Retain outer carton for full product uses, directions and warnings.

TO INCREASE YOUR SUCCESS IN QUITTING:

  • 1.You must be motivated to quit.
  • 2. Use Enough - Use at least 9 Nicorette Lozenges per day during the first six weeks.
  • 3. Use Long Enough - Use Nicorette for the full 12 weeks.
  • 4. Use With a Support Program as directed in the enclosed User’s Guide.

Nicorette® POPPAC®

To open vial, push in child resistant band on the POPPAC with thumb.

Flip up the top of the POPPAC and remove lozenge. A small amount of powder on opening of the POPPAC is normal.

For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.com or see inside for more details

  • each lozenge contains: sodium, 18mg
  • •store at 20 - 25°C (68 - 77°F)
  • •keep POPPAC tightly closed and protect from light

NICORETTE, POPPAC and the NICORETTE sunburst design are registered trademarks of the GlaxoSmithKline group of companies.

Distributed By:

GlaxoSmithKline Consumer Healthcare, L.P.

Moon Township, PA 15108

Made in Switzerland.

  • •not for sale to those under 18 years of age
  • •proof of age required
  • •not for sale in vending machines or from any source where proof of age cannot be verified

TAMPER EVIDENT FEATURE: Do not use if clear neckband printed “SEALED FOR SAFETY” is missing or broken.

Retain outer carton for full product uses, directions and warnings.

TO INCREASE YOUR SUCCESS IN QUITTING:

  • •You must be motivated to quit.
  • Use Enough - Use at least 9 Nicorette Lozenges per day during the first six weeks.
  • Use Long Enough - Use Nicorette for the full 12 weeks.
  • Use With a Support Program as directed in the enclosed User’s Guide.

Nicorette® POPPAC®

To open vial, push in child resistant band on the POPPAC with thumb.

Flip up the top of the POPPAC and remove lozenge. A small amount of powder on opening of the POPPAC is normal.

For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.com or see inside for more details

aspartame, calcium polycarbophil, flavor, magnesium stearate, mannitol, potassium bicarbonate, sodium alginate, sodium carbonate, xanthan gum

acacia, aspartame, calcium polycarbophil, corn syrup solids, flavors, lactose, magnesium stearate, maltodextrin, mannitol, potassium bicarbonate, sodium alginate, sodium carbonate, soy protein, triethyl citrate, xanthan gum

acesulfame potassium, benzyl alcohol, butylhydroxy toluene, calcium polycarbophil, coconut and/or palm kernel oil, eugenol, flavors, magnesium stearate, maltodextrin, mannitol, modified corn starch, potassium bicarbonate, sodium alginate, sodium carbonate, xanthan gum

call toll-free 1-888-569-1743 (English/Spanish) weekdays (9:00 am - 4:30 pm ET)

Principal Display Panel

NDC 0135-0514-03

Nicorette®

nicotine polacrilex lozenge, 2mg

stop smoking aid

Lozenge

NEW DIRECTIONS FOR USE

  • •Keep Using if You Slip Up and Have a Cigarette
  • •Use Beyond 12 Weeks if Needed to Quit

Includes User’s Guide

2mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE MORE THAN 30 MINUTES AFTER WAKING UP. If you smoke your first cigarette WITHIN 30 MINUTES of waking up, use Nicorette 4mg Lozenge

Original

108 Lozenges, 2mg Each

©2013 GlaxoSmithKline

30743XC

Principal Display Panel

NDC 0135-0515-03

Nicorette®

nicotine polacrilex lozenge, 4mg

stop smoking aid

Lozenge

NEW DIRECTIONS FOR USE

  • •Keep Using if You Slip Up and Have a Cigarette
  • •Use Beyond 12 Weeks if Needed to Quit

Includes User’s Guide

4mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP. If you smoke your first cigarette MORE THAN 30 MINUTES after waking up, use Nicorette 2mg Lozenge

Original

108 Lozenges, 4mg Each

©2013 GlaxoSmithKline

30744XC

Principal Display Panel

NDC 0135-0510-01

Nicorette®

nicotine polacrilex lozenge, 2mg

stop smoking aid

Lozenge

NEW DIRECTIONS FOR USE

  • •Keep Using if You Slip Up and Have a Cigarette
  • •Use Beyond 12 Weeks if Needed to Quit

Includes User’s Guide

2mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE MORE THAN 30 MINUTES AFTER WAKING UP. If you smoke your first cigarette WITHIN 30 MINUTES of waking up, use Nicorette 4mg Lozenge

Mint

72 Lozenges, 2mg Each

(3 Poppac ® Containers of 24)

©2013 GlaxoSmithKline

30741XC

Principal Display Panel

NDC 0135-0511-01

Nicorette®

nicotine polacrilex lozenge, 4mg

stop smoking aid

Lozenge

NEW DIRECTIONS FOR USE

  • •Keep Using if You Slip Up and Have a Cigarette
  • •Use Beyond 12 Weeks if Needed to Quit

Includes User’s Guide

4mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP. If you smoke your first cigarette MORE THAN 30 MINUTES after waking up, use Nicorette 2mg Lozenge

Mint

72 Lozenges, 4mg Each

(3 Poppac ® Containers of 24)

©2013 GlaxoSmithKline

30742XC

Principal Display Panel

NDC 0135-0512-01

Nicorette®

nicotine polacrilex lozenge, 2mg

stop smoking aid

Lozenge

NEW DIRECTIONS FOR USE

  • •Keep Using if You Slip Up and Have a Cigarette
  • •Use Beyond 12 Weeks if Needed to Quit

Includes User’s Guide

2mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE MORE THAN 30 MINUTES AFTER WAKING UP. If you smoke your first cigarette WITHIN 30 MINUTES of waking up, use Nicorette 4mg Lozenge

Cherry

72 Lozenges, 2mg Each

(3 Poppac® Containers of 24)

©2013 GlaxoSmithKline

30747XC

Principal Display Panel

NDC 0135-0513-01

Nicorette®

nicotine polacrilex lozenge, 4mg

stop smoking aid

Lozenge

NEW DIRECTIONS FOR USE

  • •Keep Using if You Slip Up and Have a Cigarette
  • •Use Beyond 12 Weeks if Needed to Quit

Includes User’s Guide

4mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP. If you smoke your first cigarette MORE THAN 30 MINUTES after waking up, use Nicorette 2mg Lozenge

Cherry

72 Lozenges, 4mg Each

(3 Poppac ® Containers of 24)

©2013 GlaxoSmithKline

30748XC

NICORETTE

nicotine polacrilex LOZENGE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0135-0514
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
nicotine NICOTINE 2 mg

Inactive Ingredients

Ingredient Name Strength
POLACRILIN
ASPARTAME
CALCIUM POLYCARBOPHIL
MAGNESIUM STEARATE
mannitol
POTASSIUM BICARBONATE
SODIUM ALGINATE
SODIUM CARBONATE
XANTHAN GUM

Product Characteristics

Color Size Imprint Code Shape
WHITE (white to off-white) 16 mm NL2 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 BLISTER PACK
2 12 in 1 BLISTER PACK
3 NDC:0135-0514-04 11 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021330 2010-10-19


NICORETTE

nicotine polacrilex LOZENGE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0135-0515
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
nicotine NICOTINE 4 mg

Inactive Ingredients

Ingredient Name Strength
POLACRILIN
ASPARTAME
CALCIUM POLYCARBOPHIL
MAGNESIUM STEARATE
mannitol
POTASSIUM BICARBONATE
SODIUM ALGINATE
SODIUM CARBONATE
XANTHAN GUM

Product Characteristics

Color Size Imprint Code Shape
WHITE (white to off-white) 16 mm NL4 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 BLISTER PACK
2 12 in 1 BLISTER PACK
3 NDC:0135-0515-04 11 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021330 2010-10-19


NICORETTE

nicotine polacrilex LOZENGE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0135-0510
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
nicotine NICOTINE 2 mg

Inactive Ingredients

Ingredient Name Strength
POLACRILIN
ACACIA
ASPARTAME
CALCIUM POLYCARBOPHIL
CORN SYRUP
LACTOSE
MAGNESIUM STEARATE
maltodextrin
mannitol
POTASSIUM BICARBONATE
SODIUM ALGINATE
SODIUM CARBONATE
SOY PROTEIN
TRIETHYL CITRATE
XANTHAN GUM

Product Characteristics

Color Size Imprint Code Shape
WHITE (white to off-white) 16 mm NL2S ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 24 in 1 CONTAINER
2 24 in 1 CONTAINER
3 27 in 1 CONTAINER
4 27 in 1 CONTAINER
5 NDC:0135-0510-03 7 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021330 2010-10-19


NICORETTE

nicotine polacrilex LOZENGE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0135-0511
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
nicotine NICOTINE 4 mg

Inactive Ingredients

Ingredient Name Strength
POLACRILIN
ACACIA
ASPARTAME
CALCIUM POLYCARBOPHIL
CORN SYRUP
LACTOSE
MAGNESIUM STEARATE
maltodextrin
mannitol
POTASSIUM BICARBONATE
SODIUM ALGINATE
SODIUM CARBONATE
SOY PROTEIN
TRIETHYL CITRATE
XANTHAN GUM

Product Characteristics

Color Size Imprint Code Shape
WHITE (white to off-white) 16 mm NL4S ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 24 in 1 CONTAINER
2 24 in 1 CONTAINER
3 27 in 1 CONTAINER
4 27 in 1 CONTAINER
5 NDC:0135-0511-03 7 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021330 2010-10-19


NICORETTE

nicotine polacrilex LOZENGE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0135-0512
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
nicotine NICOTINE 2 mg

Inactive Ingredients

Ingredient Name Strength
POLACRILIN
ACESULFAME POTASSIUM
BENZYL ALCOHOL
BUTYLATED HYDROXYTOLUENE
CALCIUM POLYCARBOPHIL
COCONUT OIL
PALM KERNEL OIL
Eugenol
MAGNESIUM STEARATE
maltodextrin
mannitol
MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)
POTASSIUM BICARBONATE
SODIUM ALGINATE
SODIUM CARBONATE
XANTHAN GUM

Product Characteristics

Color Size Imprint Code Shape
WHITE (white to off-white) 16 mm NL2C ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 24 in 1 CONTAINER
2 27 in 1 CONTAINER
3 NDC:0135-0512-05 3 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021330 2010-10-19


NICORETTE

nicotine polacrilex LOZENGE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0135-0513
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
nicotine NICOTINE 4 mg

Inactive Ingredients

Ingredient Name Strength
POLACRILIN
ACESULFAME POTASSIUM
BENZYL ALCOHOL
BUTYLATED HYDROXYTOLUENE
CALCIUM POLYCARBOPHIL
COCONUT OIL
PALM KERNEL OIL
Eugenol
MAGNESIUM STEARATE
maltodextrin
mannitol
MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)
POTASSIUM BICARBONATE
SODIUM ALGINATE
SODIUM CARBONATE
XANTHAN GUM

Product Characteristics

Color Size Imprint Code Shape
WHITE (white to off-white) 16 mm NL4C ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 24 in 1 CONTAINER
2 27 in 1 CONTAINER
3 NDC:0135-0513-05 3 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021330 2010-10-19


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.